2017
DOI: 10.1016/j.anai.2016.12.008
|View full text |Cite
|
Sign up to set email alerts
|

Intrauterine uterine contraception and chronic urticaria: a case series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…However, the study did not specify the dosages of progesterone in their IUDs. Thus, we cannot confirm if Skyla® caused symptoms in any of these patients [ 5 ]. Two papers described the incidence of acute urticarial rash in patients two hours after implantation of Mirena®, with a resolution of the rash after IUD removal [ 1 , 9 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…However, the study did not specify the dosages of progesterone in their IUDs. Thus, we cannot confirm if Skyla® caused symptoms in any of these patients [ 5 ]. Two papers described the incidence of acute urticarial rash in patients two hours after implantation of Mirena®, with a resolution of the rash after IUD removal [ 1 , 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…Pathogenesis is poorly understood. There may be a combination of both type I and IV immune reactions through a T-helper (Th2) lymphocyte-mediated reaction [ 1 , 4 , 5 ]. Sensitization may occur from cross-sensitivity between progesterone products in the production of immunoglobulin E synthesis [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations